Although weight loss surgery (bariatric surgery) can be beneficial in reducing liver fat and damage, and in decreasing the risk of further health complications, it is typically not recommended as a standalone treatment for NASH. Instead, it may be indicated in individuals with NASH with moderate to severe (Class II or Class III) obesity and/or those who have other cardiometabolic comorbidities such as type 2 diabetes.
Weight loss surgery is not recommended for people with decompensated liver cirrhosis, as it can increase the risk for postoperative complications and mortality.[1][2]
References
- ^Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin SNonalcoholic Steatohepatitis: A Review.JAMA.(2020-Mar-24)
- ^Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W Timothy Garvey, Sangeeta Kashyap, Jeffrey I Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E Rinella, Miriam B Vos, Zobair YounossiAmerican Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)Endocr Pract.(2022 May)